MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

Search

Insulet Corp

Uždarymo kaina

SektoriusSveikatos priežiūra

300.77 0.03

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

296.95

Max

301.32

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-65M

35M

Pardavimai

-29M

569M

P/E

Sektoriaus vid.

56.711

40.527

Pelno marža

6.221

Darbuotojai

3,900

EBITDA

-53M

89M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+11.92% upside

Dividendai

By Dow Jones

Kitas uždarbis

2025-08-07

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

2.4B

22B

Ankstesnė atidarymo kaina

300.74

Ankstesnė uždarymo kaina

300.77

Naujienos nuotaikos

By Acuity

34%

66%

95 / 375 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Weak Bearish Evidence

Insulet Corp Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-07-03 23:45; UTC

Įsigijimai, susijungimai, perėmimai

Orix Corp. USA to Buy Majority Stake in Hilco Global >8591.TO

2025-07-03 23:42; UTC

Rinkos pokalbiai

Gold Edges Higher Amid U.S. Fiscal-Deficit Concerns -- Market Talk

2025-07-03 23:41; UTC

Rinkos pokalbiai

Nikkei May Rise After Solid U.S. Jobs Data -- Market Talk

2025-07-03 23:41; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-07-03 23:15; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Beach Energy Could Smooth Path to Santos Takeover Approval -- Market Talk

2025-07-03 22:59; UTC

Rinkos pokalbiai

Uranium Market About to Enter Lull -- Market Talk

2025-07-03 22:58; UTC

Rinkos pokalbiai

Value Emerging in Diversified Miners Despite Headwinds -- Market Talk

2025-07-03 22:47; UTC

Rinkos pokalbiai

Australian Household Spending Numbers Key Ahead of RBA Meeting -- Market Talk

2025-07-03 22:21; UTC

Uždarbis

This Summer's Big TV Hit Brings Back Soap Opera Memories -- Barrons.com

2025-07-03 20:50; UTC

Rinkos pokalbiai

Financial Services Roundup: Market Talk

2025-07-03 20:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-07-03 20:50; UTC

Rinkos pokalbiai

Health Care Roundup: Market Talk

2025-07-03 20:41; UTC

Rinkos pokalbiai

KKR Seen As Benefiting From Stabilizing Markets -- Market Talk

2025-07-03 20:41; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2025-07-03 19:28; UTC

Rinkos pokalbiai

Oil Gives Back Some Gains With OPEC+ in View -- Market Talk

2025-07-03 19:03; UTC

Rinkos pokalbiai

U.S. Natural Gas Retreats Ahead of Long Weekend -- Market Talk

2025-07-03 18:34; UTC

Rinkos pokalbiai

Gold Has Winning Week, But Down Day -- Market Talk

2025-07-03 18:18; UTC

Rinkos pokalbiai

Anticipation for Trump Address Gives Grain Traders Optimism -- Market Talk

2025-07-03 18:06; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2025-07-03 18:06; UTC

Rinkos pokalbiai

Brazilian Stocks, Bonds Expected to Benefit From Benign Macro Trends -- Market Talk

2025-07-03 17:27; UTC

Rinkos pokalbiai

U.S. Oil Rig Count Continues to Slide -- Market Talk

2025-07-03 16:55; UTC

Uždarbis

Travel Stocks Could Offer Investors a Glorious -2-

2025-07-03 16:55; UTC

Uždarbis

Travel Stocks Could Offer Investors a Glorious Trip, This Analyst Says -- Barrons.com

2025-07-03 16:20; UTC

Rinkos pokalbiai

Correction to Health Care Roundup: Market Talk

2025-07-03 16:15; UTC

Rinkos pokalbiai

Oil Futures Lose Ground in Choppy Pre-Holiday Trade -- Market Talk

2025-07-03 16:15; UTC

Rinkos pokalbiai

Global Commodities Roundup: Market Talk

2025-07-03 16:05; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-07-03 16:05; UTC

Rinkos pokalbiai

Gold Futures Fall Following Jobs Report -- Market Talk

2025-07-03 15:47; UTC

Uždarbis

Honeywell Stock Is on a Roll. It Looks Ready to Break Out. -- Barrons.com

2025-07-03 15:36; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

Why It's Time to Buy This Rocks and Cement Spinoff Stock You've Probably Never Heard Of -- Barrons.com

Akcijų palyginimas

Kainos pokytis

Insulet Corp Prognozė

Kainos tikslas

By TipRanks

11.92% į viršų

12 mėnesių prognozė

Vidutinis 337.56 USD  11.92%

Aukščiausias 380 USD

Žemiausias 266 USD

Remiantis 21 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Insulet Corp kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

21 ratings

19

Pirkti

2

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

252.29 / 259.38Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Weak Bearish Evidence

Vidutinės trukmės periodas

Strong Bearish Evidence

Ilgalaikis periodas

Bullish Evidence

Rinkos nuotaikos

By Acuity

95 / 375 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Insulet Corp

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.